Cargando…
Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer
INTRODUCTION: Tumorigenesis in breast cancers usually accompanied by the dysregulation of transcription factors (TFs). Abnormal amplification of TFs leads aberrant expression of its downstream target genes. However, breast cancers are heterogeneous disease with different subtypes that have distingui...
Autores principales: | Zheng, Jing, Huang, Jingyi, Xia, Jinquan, Zhou, Wenbin, Dai, Lingyun, Lin, Sihang, Gao, Lin, Zou, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939474/ https://www.ncbi.nlm.nih.gov/pubmed/36814821 http://dx.doi.org/10.3389/fonc.2023.1038787 |
Ejemplares similares
-
Clinical and Dermoscopic Factors for the Identification of Aggressive Histologic Subtypes of Basal Cell Carcinoma
por: Pampena, Riccardo, et al.
Publicado: (2021) -
GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer
por: Wu, Liang, et al.
Publicado: (2023) -
Small Nuclear Ribonucleoprotein Polypeptide N Accelerates Malignant Progression and Poor Prognosis in Colorectal Cancer Transcriptionally Regulated by E2F8
por: Ji, Meiling, et al.
Publicado: (2020) -
Interleukin-31 Receptor α Is Required for Basal-Like Breast Cancer Progression
por: He, Yanling, et al.
Publicado: (2020) -
Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Jiang, Jiahong, et al.
Publicado: (2021)